###begin article-title 0
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Polymorphism in the oxytocin promoter region in patients with lactase non-persistence is not related to symptoms
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR</italic>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
Oxytocin and the oxytocin receptor have been demonstrated in the gastrointestinal (GI) tract and have been shown to exert physiological effects on gut motility. The role for oxytocin in the pathophysiology of GI complaints is unknown. The aim of this study was to examine genetic variations or polymorphism of oxytocin (OXT) and its receptor (OXTR) genes in patients with GI complaints without visible organic abnormalities.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Genetic variants in the OXT promoter region, and in the OXTR gene in DNA samples from 131 rigorously evaluated patients with Irritable Bowel Syndrome (IBS), 408 homozygous subjects referred for lactase (LCT-13910 C>T, rs4988235) genotyping, and 299 asymptomatic blood donors were compared. One polymorphism related to the OXT gene (rs6133010 A>G) and 4 related to the OXTR gene (rs1465386 G>T, rs3806675 G>A, rs968389 A>G, rs1042778 G>T) were selected for genotyping using Applied Biosystems 7900 HT allele discrimination assays.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 780 784 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
There were no statistically significant differences in the genotype or allele frequencies in any of the SNPs when IBS patients were compared to healthy controls. Among subjects referred for lactase genotyping, the rs6133010 A>G OXT promoter A/G genotype tended to be more common in the 154 non-persistent (27.3%) subjects than in the 254 lactase persistant (18.1%) subjects and in the healthy controls (19.4%) (p = 0.08). When direct comparing, the A/G genotype was less common in the OXT promoter region in controls (p = 0.09) and in subjects with lactase persistence (p = 0.03) compared to subjects with lactase non-persistence. When healthy controls were viewed according to their own LCT-13910 genotypes, the C/C lactase non-persistent controls had a higher frequency for the OXT promoter A/G genotype than LCT-13910 T/T lactase persistent controls (41.2% vs 13.1%).
###end p 6
###begin p 7
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
No significant differences in frequencies of the investigated OXTR SNPs were noted in this study.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
The results suggest that polymorphism in the promoter region of the OXT gene is most common in subjects with lactase non-persistence. This polymorphism may not be related to GI symptoms, as it is related to lactase non-persistence also in healthy controls.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 886 887 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
Gastrointestinal (GI) complaints in the form of abdominal pain and altered bowel movements are very common in the population, and in most cases, remain unexplained despite extensive diagnostic evaluations. These patients are classified as suffering from functional bowel diseases [1]. Frequently indistinguishable symptoms are seen in the subgroup of patients with lactase non-persistence, which is also common in the adult population [2,3], and reported complaints in this group are surprisingly less correlated to the volume of milk intake, than previously assumed [4]. Differences in gastric emptying and individual perception of symptoms have been discussed [5,6]. Many neuropeptides, e.g. serotonin and norepinephrine, are involved in the regulation of GI sensitivity and motility, and polymorphism in these peptides has been suggested as another possible explanation to symptoms [7-9].
###end p 11
###begin p 12
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
Oxytocin was long thought to be a hormone primarily involved in parturition and suckling. Recently, oxytocin expression has been found in the gut [10,11], where it is secreted after a fatty meal [12] and stimulates colonic activity [13]. It has further been demonstrated that systemic administration of oxytocin leads to enhanced gastric emptying [14,15] and that the oxytocin receptor antagonist atosiban significantly delays gastric emptying [16]. In accordance to this, diabetic patients with gastro paresis have no demonstrable postprandial oxytocin release [17].
###end p 12
###begin p 13
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
The aim of this study was thus to examine whether genetic variation or polymorphism in the OXT or OXTR genes may explain the pathology in numerous patients with GI complaints without organic explanation.
###end p 13
###begin title 14
Methods
###end title 14
###begin p 15
This study was performed according to the Helsinki declaration and approved by the Ethics Committee of Lund University.
###end p 15
###begin title 16
Study Population
###end title 16
###begin p 17
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
###xml 456 464 <span type="species:ncbi:9606">patients</span>
###xml 772 780 <span type="species:ncbi:9606">patients</span>
###xml 859 867 <span type="species:ncbi:9606">patients</span>
One hundred and thirty-one patients (108 females), mean age 38.2 +/- 15.1 years, range 20-78 years, who have undergone rigorous evaluations for GI complaints at tertiary care centres in Malmo (N = 43) and in Gothenburg (N = 88) were included in the study. LCT genotyping was performed, and 13 patients were found to have LCT-13910 C/C, 76 patients had LCT-13910 T/T and 38 patients were heterocygotes. In the absence of evident organic disease, and as the patients with LCT-13910 C/C had persistent GI complaints after elimination of milk products in the food, they were regarded as having irritable bowel syndrome (IBS) (1, 3). They had predominantly constipation (N = 35), diarrhoea (N = 35) or mixed symptoms (N = 59), whereas clinical subgroups were not defined for 2 patients. Samples and written informed consent for this study were obtained from these patients and from 299 healthy adult blood donors (99 females), mean age 64.5 +/- 13.0 years, range 41-85 years, who negated all forms of abdominal pain or abnormal bowel habits on a written questionnaire.
###end p 17
###begin p 18
###xml 503 511 <span type="species:ncbi:9606">patients</span>
Remnant samples submitted from an additional 319 subjects from predominantly primary care centres to screen for potential lactase non-persistence by analysis of LCT-13910C>T (rs4988235), and who had had homozygous C/C or T/T genotypes were also included in this pilot study. After initial registration of age, sex and genotype, all personal identifiers associated with the samples were destroyed. This procedure is in accordance with the Swedish biobank law. These samples were put together with the 89 patients from tertiary care centres with either homocygous for C/C or T/T. Of these totally 408 subjects, 154 (mean age 30.5 +/- 18.2 years, range 3-76 years, 113 females) were LCT-13910 C/C homozygotes for lactase non-persistence and 254 (mean age 36.8 +/- 19.3 years, range 2-81 years, 189 females) were LCT-13910 T/T homozygotes for lactase persistence. Heterozygous C/T samples were excluded from this study to avoid ambiguity in interpretation. Although the samples were not consistently tested for adjacent LCT variants, e.g. LCT-13907 C>G and LCT-13915 T>G, these when rarely present, are frequently noted outside of the main LCT-13910 C/C or C/T clusters. This is seen in 1-2% of samples at our laboratory and was not expected to interfere with interpretations of our results.
###end p 18
###begin title 19
SNP selection
###end title 19
###begin p 20
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 402 406 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 444 449 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 488 493 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 527 532 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 563 568 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
The OXT gene is located on chromosome 20p13 [18] and the OXTR gene is located on chromosome 3p26 [19]. Some transcript variants have been identified in these genes. We conducted an extensive search using Entrez SNP [20] and HapMap genome browser [21] databases for known SNPs in and immediately up- and downstream of the OXT and OXTR genes. Five SNPs with heterozygosity of >/= 5% were identified; the OXT promoter region (rs61333010 A>G), the OXTR 5'promoter region (rs3806675 G>A), the OXTR 5'hap marker (rs1465386 G>T), the OXTR exon 1 (rs1042778 G>T) and the OXTR exon 4 (rs968389A>G).
###end p 20
###begin title 21
DNA analysis
###end title 21
###begin p 22
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
DNA was extracted from fresh EDTA whole blood using QiaAmp minikits (Qiagen GmbH, Germany) according to the manufacturer's instructions. Genotyping of all SNPs was performed according to the standard protocol at the Department of Clinical Chemistry at Malmo University Hospital, using commercially available SNP genotyping (Applied Biosystems) on an Applied Biosystems 7900 HT instrument, no UNG mastermix and the recommended PCR program. Specific assays were C_30100478_10 for rs6133010, C_7622000_0 for rs968389, and C_7622140_30 for rs1042778. Assays by design were acquired for rs4988235, rs14653886 and rs3806675. All samples, including the primary care subjects were then analysed with all assays in the LCT, OXT and OXTR genes.
###end p 22
###begin title 23
Statistical analyses
###end title 23
###begin p 24
Fisher's exact test was used for comparison between groups, and odds ratio (OR) and confidence interval (CI) were calculated. Mann Whitney U test was used for calculations of differences in ages between groups. P < 0.05 was considered statistically significant.
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
When comparing IBS patients from tertiary care centres to healthy controls, no overall statistical significant differences were observed in genotype or allele frequencies (data not shown). There was no association between symptoms and genotype in any of the selected SNPs in the OXT and OXTR genes (Table 1 and 2, other data not shown).
###end p 26
###begin p 27
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT</italic>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Genotype frequency of the oxytocin (OXT) promoter region rs6133010 A>G in patients, subjects and controls
###end p 27
###begin p 28
###xml 42 50 <span type="species:ncbi:9606">patients</span>
* = Comparisons made between subgroups of patients with Irritable Bowel Syndrome (IBS).
###end p 28
###begin p 29
** = Comparisons made between controls and lactase persistent- and lactase non-persistent subjects.
###end p 29
###begin p 30
Fisher's exact test.
###end p 30
###begin p 31
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Genotype frequency of the oxytocin receptor (OXTR) 5'promoter region rs3806675 G>A in patients with lactase non-persistence or lactase persistence
###end p 31
###begin p 32
###xml 42 50 <span type="species:ncbi:9606">patients</span>
* = Comparisons made between subgroups of patients with Irritable Bowel Syndrome (IBS).
###end p 32
###begin p 33
** = Comparisons made between controls and lactase persistent- and lactase non-persistent subjects.
###end p 33
###begin p 34
Fisher's exact test.
###end p 34
###begin p 35
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXTR </italic>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
As genotypes in patients with known IBS did not differ from controls, we examined whether there were any differences between subjects with or without lactase persistence, according to their OXT or OXTR genotypes. There was no difference in age between the lactase non-persistent or lactase persistent group (p = 0.39), whereas there was a significantly higher age in the controls compared to both subject groups (p < 0.00). When the whole study population was included, there was no difference between females and males, or between presumably pre- or postmenopausal subjects (age < or > 50 years of age) in relation to the selected SNPs in the OXT and OXTR genes (data not shown).
###end p 35
###begin p 36
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
When the controls were compared to lactase-persitent and lactase non-persistent subjects, there was a tendency to significance in the genotype frequency in the OXT promoter region (rs6133010 A>G) (Table 1). When comparing allele frequencies, there was no significant difference (Table 3). Calculation of odds ratio and confidence interval for the allele frequencies showed no difference between controls and lactase persistent subjects (OR: 0.89; CI 0.50-1.58; P = 0.77), or between controls and lactase non-persistent subjects (OR: 1.49; CI: 0.83-2.69; P = 0.21).
###end p 36
###begin p 37
Allele frequencies of the oxytocin (OXT) promoter region rs6133010 A>G in controls and in subjects with lactase non-persistence or lactase persistence
###end p 37
###begin p 38
Fisher's exact test. P = 0.24
###end p 38
###begin p 39
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 731 739 <span type="species:ncbi:9606">patients</span>
Although there was no difference in allele frequencies for rs6133010 A>G (OR: 0.60; CI: 0.32-1.11; P = 0.11) between LCT-13910 C/C or T/T subjects, T/T (lactase persistent) subjects were less likely to have the A/G genotype for this SNP in the OXT promoter region (P = 0.03). A slightly lower frequency of this A/G genotype was also seen in healthy controls compared to lactase non-persistent (LCT-13910 C/C) subjects (P = 0.09), with no difference between controls and lactase persistent subjects (P = 0.86). The frequency of the A/A genotype in the different study groups is shown in Table 1. When regarding the asymptomatic blood donors according to their LCT genotype, the frequency of LCT-13910 C/C was 8%, similar to the IBS patients from the tertiary care centre (10%). The lactase non-persistent asymptomatic controls had a frequency of the rs6133010 A/G genotype in 41%, compared to 13% in the lactase persistent controls.
###end p 39
###begin p 40
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
In the OXTR 5'promoter region (rs3806675 G>A) there was a trend towards higher A/A genotype in relation to G/G genotype in lactase persistent subjects compared to non-persistent subjects (Table 2), although allele frequencies did not differ between the groups (OR: 0.72; CI: 0.48-1.08; P = 0.12).
###end p 40
###begin p 41
There were no differences in genotype or allele frequencies in the other parts of OXT or OXTR genes examined (data not shown).
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
Among patients with unexplained GI complaints referred for lactase (LCT-13910 C>T) genotyping, a significant difference was found in genotype frequency of a SNP in the OXT promoter region gene between LCT-13910 C/C (non-persistent) and T/T (persistent) subjects. This polymorphism was observed also in asymptomatic controls when these were divided according to C/C and T/T.
###end p 43
###begin p 44
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 611 612 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1188 1189 1188 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1190 1191 1190 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 284 292 <span type="species:ncbi:9606">Patients</span>
###xml 502 510 <span type="species:ncbi:9606">patients</span>
###xml 662 670 <span type="species:ncbi:9606">patients</span>
The symptoms leading to admission for lactase genotyping is abdominal complaints after lactose intake in the form of abdominal pain and bloating, diarrhoea and an excess of gas. These symptoms are often impossible to differ from functional bowel diseases without making a genotyping. Patients referred for lactase genotyping who do not carry the lactase non-persistence genotype, may in the majority of cases suffer from functional bowel diseases [1]. Even among lactase non-persistence subjects, many patients suffer from functional bowel diseases, and although reducing the milk intake, the symptoms persist [4]. In the present study, we chose only homozygote patients to obtain well-defined groups concerning lactase persistence, as individual variations in the lactose absorption, particularly among heterozygotes have been reported [2,4]. Factors causing this variation of symptoms in response to the same volume of milk intake, or according to different milk products, may include the amount of lactose not absorbed in the gut, differences in the bacterial flora and their metabolism of lactose in colon [22], and the rate of gastric emptying and individual perception of symptoms [5,6]. In the present study, the A/A genotype of rs6133010 in the promoter region of the OXT gene was more frequent in asymptomatic controls and in lactase persistent subjects than in lactase non-persistent, although statistically significant only in persistent subjects. This suggests that the A/A genotype regulates the GI physiology in a different way compared to A/G. However, when comparing the LCT-13910 genotype in asymptomatic controls, C/C homozygous controls had the highest A/G frequency of all groups. Although the small sample size, this finding suggests that A/G may not be an important factor for the symptomatology, but is coupled to other factors such as LCT-13910 C/C.
###end p 44
###begin p 45
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
During the last years, further genotypes associated with lactase persistence/non-persistence, e.g. LCT-13907C>G and LCT-13915T>G, have been described [23]. These genotypes were not tested for in the actual study. However, as these genotypes are uncommon, and only a minority of the population in Sweden comes from the part of the world where these genotypes are most frequent, this may not obscure the picture.
###end p 45
###begin p 46
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:9606">women</span>
Previously it has been suggested that oxytocin play a role in the regulation of GI physiology as it has been found in both the myenteric and submucous ganglia in the human GI tract [11]. It is released in response to a fatty meal [12] and has been shown to accelerate gastric emptying [14,15], whereas the oxytocin receptor antagonist atosiban inhibited gastric emptying [16]. Furthermore, oxytocin stimulated colonic peristalsis in healthy women [13]. On the other hand, studies in animals have shown that oxytocin inhibited gastric emptying [24] and contractile motility of the proximal [25] and distal colon [26]. Possible explanation to these divergent results are differences in methods i.e.; dose and administration of oxytocin, in species studied, or in the region of the GI tract examined. Nothing has been described about the role of oxytocin in the pathophysiology of disturbances of GI motility.
###end p 46
###begin p 47
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 259 263 <span type="species:ncbi:10116">rats</span>
###xml 346 354 <span type="species:ncbi:9606">patients</span>
Abdominal pain is the most frequent complaint among GI disturbances. Continuous infusion of oxytocin significantly elevated thresholds for visceral perception of colonic discomfort in patients with IBS [27], and increased the threshold for peripheral pain in rats [28]. Nasal administration of oxytocin had a positive effect on abdominal pain in patients with IBS [29]. Altogether, this suggests oxytocin to be involved in pain regulation, which is further supported by the expression of the peptide in the dorsal root ganglia [30] and its widely spread presence in the central nervous system [31].
###end p 47
###begin p 48
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT</italic>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 47 50 <span type="species:ncbi:10116">rat</span>
###xml 175 179 <span type="species:ncbi:10116">rats</span>
###xml 335 338 <span type="species:ncbi:9606">men</span>
###xml 387 390 <span type="species:ncbi:9606">men</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
###xml 826 834 <span type="species:ncbi:9606">patients</span>
###xml 963 971 <span type="species:ncbi:9606">patients</span>
###xml 1078 1086 <span type="species:ncbi:9606">patients</span>
###xml 1191 1199 <span type="species:ncbi:9606">patients</span>
###xml 1304 1312 <span type="species:ncbi:9606">patients</span>
Estradiol regulates the OXT-gene expression in rat uterus [32]. Recently, it has been shown that estradiol upregulates the oxytocin receptor in the enteric plexus of colon in rats and increases the colon sensitivity to the excitatory effect of oxytocin on colon motility [33]. Females have higher levels of oxytocin and estradiol than men [34], and IBS is more common in females than in men [35]. In female patients suffering from IBS, blood estradiol and oxytocin levels were significantly lower than in control groups [36,37]. As many GI complaints debute at an age when the estradiol levels fall, lower expression of oxytocin receptors has been one hypothesis for the etiology of GI disturbances. However, differences in hormonal plasma levels may be secondary, and not causal. When comparing the genotype frequency in IBS patients in the table over rs6133010 A>G, the OXT gene promoter region which is closely coupled to estradiol [32,38], it seems as though patients with mixed IBS have similar frequencies of the genotypes as healthy controls, and diarrhoea-dominated IBS patients resemble subjects with lactase non-persistence. This finding raises the hypothesis that the symptoms in patients with lactase non-persistence, irrespective of milk intake, may depend on genetic factors resembling IBS patients with diarrhoea. This should be further evaluated in larger studies. However, we could not find any association between gender and polymorphism in the examined SNPs.
###end p 48
###begin p 49
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 573 577 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 196 202 <span type="species:ncbi:9606">people</span>
###xml 277 283 <span type="species:ncbi:9606">people</span>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
A limitation of this pilot study is the small sample size, and our lack of information concerning specific symptoms in subjects referred for LCT-13910 genotyping from the primary care centres. As people from northern Europe have a higher prevalence of lactase persistence than people from southern Europe, Africa and Asia [39], we can assume that the group of lactase non-persistent subjects contained a larger proportion of subjects with a non-Nordic background. These differences in ethnicity can possibly explain the genetic variation to some extent. Alternatively, the OXT promoter G allele may lead to increased pain, and thus increased medical evaluation, in patients with lactase non-persistence.
###end p 49
###begin title 50
Conclusion
###end title 50
###begin p 51
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OXT </italic>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
Our investigation has shown significant differences in genotype frequencies of a SNP in the promoter region of the OXT gene in patients with lactase non-persistence. The role of this polymorphism in the pathophysiology and symptomatology of GI complaints remains obscure, as the polymorphism was also present in healthy LCT C/C homozygous controls.
###end p 51
###begin title 52
Abbreviations
###end title 52
###begin p 53
GI: gastrointestinal; OXT: oxytocin; OXTR: oxytocin receptor.
###end p 53
###begin title 54
Competing interests
###end title 54
###begin p 55
The authors declare that they have no competing interests.
###end p 55
###begin title 56
Authors' contributions
###end title 56
###begin p 57
MT has substantial contributions to conception and design, analysis and interpretion of data and mainly drafting the manuscript. JC has contributed to conception and design, acquisition of data, analysis and interpretion of data and has been involved in revising the manuscript critically. MS has contributed to analysis and interpretion of data and have been involved in revising the manuscript critically. BO has contributed to conception and design, acquisition of data, analysis and interpretion of data and has been involved in drafting the manuscript. All authors have read and approved the final manuscript.
###end p 57
###begin title 58
Authors' information
###end title 58
###begin p 59
MT is PhD student and Specialist in Internal Medicine, JC is Associated professor and Senior Consultant of Gastroenterology and Hepatology, MS is Associated professor and Senior Consultant of Gastroenterology and Hepatology, BO is Professor in Medicine and Senior Consultant of Gastroenterology and Hepatology
###end p 59
###begin title 60
Pre-publication history
###end title 60
###begin p 61
The pre-publication history for this paper can be accessed here:
###end p 61
###begin p 62

###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
This study was supported by grants from the Foundation of Capio, the Magnus Bergvall Foundation and the Foundation of Ernold Lundstrom and Foundation of Malmo University Hospital.
###end p 64
###begin article-title 65
Functional bowel disorders
###end article-title 65
###begin article-title 66
###xml 62 68 <span type="species:ncbi:9606">people</span>
Molecularly defined adult-type hypolactasia among working age people with reference to milk consumption and gastrointestinal symptoms
###end article-title 66
###begin article-title 67
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Lactase persistence/non-persistence variants, C/T_13910 and G/A_2 as a diagnostic tool for lactose intolerance in IBS patients
###end article-title 67
###begin article-title 68
Review article: lactose intolerance in clinical practice--myths and realities
###end article-title 68
###begin article-title 69
Double-blind study on the tolerance of four types of milk in lactose malabsorbers and absorbers
###end article-title 69
###begin article-title 70
Visceral hypersensitivity and intolerance symptoms in lactose malabsorption
###end article-title 70
###begin article-title 71
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
###end article-title 71
###begin article-title 72
###xml 29 31 25 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
Association of distinct alpha2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders
###end article-title 72
###begin article-title 73
Serotonin transporter gene polymorphism and irritable bowel syndrome
###end article-title 73
###begin article-title 74
###xml 54 59 <span type="species:ncbi:9606">human</span>
Oxytocin and oxytocin receptor mRNA expression in the human gastrointestinal tract: A polymerase chain reaction study
###end article-title 74
###begin article-title 75
###xml 35 40 <span type="species:ncbi:9606">human</span>
Oxytocin is present throughout the human gastrointestinal tract
###end article-title 75
###begin article-title 76
###xml 65 70 <span type="species:ncbi:9606">women</span>
Cholecystokinin leads to increased oxytocin secretion in healthy women
###end article-title 76
###begin article-title 77
###xml 54 59 <span type="species:ncbi:9606">women</span>
Oxytocin stimulates colonic motor activity in healthy women
###end article-title 77
###begin article-title 78
Prolonged post-vagotomy gastric atony treated by oxytocin
###end article-title 78
###begin article-title 79
The effect of oxytocin on basal and pethidine-induced delayed gastric emptying
###end article-title 79
###begin article-title 80
###xml 124 129 <span type="species:ncbi:9606">human</span>
The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human
###end article-title 80
###begin article-title 81
Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia and autonomic neuropathy with hypergastrinemia
###end article-title 81
###begin article-title 82
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization
###end article-title 82
###begin article-title 83
###xml 31 36 <span type="species:ncbi:9606">human</span>
Structural organization of the human oxytocin receptor gene
###end article-title 83
###begin article-title 84
Entrez SNP [cited 2008 April]
###end article-title 84
###begin article-title 85
HapMap genome browser [cited 2008 April]
###end article-title 85
###begin article-title 86
Quantitative measurement of lactose absorption
###end article-title 86
###begin article-title 87
Simultaneous genotyping of the three lactose tolerance-linked polymorhisms LCT-13907C>G, LCT-13910C>T and LCT-13915T>G with pyrosequencing technology
###end article-title 87
###begin article-title 88
###xml 98 102 <span type="species:ncbi:10116">rats</span>
Involvement of cholecystokinin receptor in the inhibition of gastric emptying by oxytocin in male rats
###end article-title 88
###begin article-title 89
###xml 37 43 <span type="species:ncbi:9986">rabbit</span>
Effect of oxytocin on contraction of rabbit proximal colon in vitro
###end article-title 89
###begin article-title 90
###xml 77 84 <span type="species:ncbi:9986">rabbits</span>
The inhibitory effects of oxytocin on distal colonic contractile activity in rabbits are enhanced by ovarian steroids
###end article-title 90
###begin article-title 91
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome
###end article-title 91
###begin article-title 92
###xml 87 91 <span type="species:ncbi:10116">rats</span>
Oxytocin increases and a specific oxytocin antagonist decreases pain threshold in male rats
###end article-title 92
###begin article-title 93
Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial
###end article-title 93
###begin article-title 94
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Modulation by oxytocin of ATP-activated currents in rat dorsal root ganglion neurons
###end article-title 94
###begin article-title 95
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Oxytocinergic inputs to the nucleus of solitary tract and dorsal motor nucleus of the vagus in neonatal rats
###end article-title 95
###begin article-title 96
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Effects of retinoic acid and estrogens on oxytocin gene expression in the rat uterus: in vitro and in vivo studies
###end article-title 96
###begin article-title 97
###xml 70 74 <span type="species:ncbi:10116">rats</span>
Estradiol upregulates the expression of oxytocin receptor in colon in rats
###end article-title 97
###begin article-title 98
###xml 34 37 <span type="species:ncbi:9606">men</span>
###xml 51 56 <span type="species:ncbi:9606">women</span>
###xml 71 76 <span type="species:ncbi:9606">women</span>
Plasma oxytocin concentrations in men, nonpregnant women, and pregnant women before and during spontaneous labor
###end article-title 98
###begin article-title 99
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time
###end article-title 99
###begin article-title 100
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Gastrin, somatostatin and oxytocin levels in patients with functional disorders of the gastrointestinal tract and their response to feeding and interaction
###end article-title 100
###begin article-title 101
Association of peripheral blood estradiol, progesterone and testosterone levels with irritable bowel syndrome
###end article-title 101
###begin article-title 102
A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens
###end article-title 102
###begin article-title 103
Genetics and epidemiology of adult-type hypolactasia
###end article-title 103

